Stay updated on BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial
Sign up to get notified when there's something new on the BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial page.

Latest updates to the BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision number (v3.6.5) replacing the previous v3.6.4, indicating a small maintenance update to the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows Revision: v3.6.4 in the footer, replacing the previous v3.6.3; this signals a software version update rather than a substantive change to the study information.SummaryDifference0.0%

- Check47 days agoChange DetectedThe site revision tag was updated from v3.6.2 to v3.6.3. This change indicates a backend/template update and does not alter the displayed study details or user-facing functionality.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the prior v3.6.0 label. This reflects a minor software update and does not change study data or page content.SummaryDifference0.0%

- Check68 days agoChange DetectedThe study details page now indicates no longer recruiting participants and adds new help/informational sections (How to Read a Study Record, Common Questions, How to Join a Study), while also updating the Intervention/Treatment label and bumping the revision to v3.6.0.SummaryDifference0.3%

- Check75 days agoChange DetectedThe page's revision tag updated from v3.5.4 to v3.5.5, indicating a newer version of the page. No study details or user-facing content appear to be modified by this change.SummaryDifference0.0%

Stay in the know with updates to BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial page.